Literature DB >> 34616873

BNIP3 in melanoma: isn't it IRONic?

Mónica Vara-Pérez1,2, Patrizia Agostinis1,2.   

Abstract

Melanoma cells exploit mitophagy and hypoxia signaling to promote their growth. In a recent study, we found that loss of B-cell lymphoma 2 (BCL-2)/adenovirus E1B 19kDa protein-interacting protein 3 (BNIP3) curbed Hypoxia Inducible Factor 1 alpha (HIF-1α) levels and melanoma growth in vivo. Insufficient levels of BNIP3 boost iron-driven prolyl hydroxylase 2 (Phd2)-mediated degradation of HIF-1α by exacerbating nuclear receptor activator 4 (Ncoa4)-mediated ferritinophagy. Thus, BNIP3 promotes melanoma growth by controlling iron metabolism.
© 2021 Taylor & Francis Group, LLC.

Entities:  

Keywords:  BNIP3; HIF-1α; autophagy; ferritinophagy; iron; melanoma; metabolism

Year:  2021        PMID: 34616873      PMCID: PMC8489953          DOI: 10.1080/23723556.2021.1947169

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

1.  BNIP3 contributes to the glutamine-driven aggressive behavior of melanoma cells.

Authors:  Monica Vara-Perez; Hannelore Maes; Sarah Van Dingenen; Patrizia Agostinis
Journal:  Biol Chem       Date:  2019-01-28       Impact factor: 3.915

Review 2.  Broadening horizons: the role of ferroptosis in cancer.

Authors:  Xin Chen; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  Nat Rev Clin Oncol       Date:  2021-01-29       Impact factor: 66.675

3.  The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.

Authors:  Sandra Barth; Jutta Nesper; Philippe A Hasgall; Renato Wirthner; Katarzyna J Nytko; Frank Edlich; Dörthe M Katschinski; Daniel P Stiehl; Roland H Wenger; Gieri Camenisch
Journal:  Mol Cell Biol       Date:  2007-03-12       Impact factor: 4.272

4.  FKBP8 recruits LC3A to mediate Parkin-independent mitophagy.

Authors:  Zambarlal Bhujabal; Åsa B Birgisdottir; Eva Sjøttem; Hanne B Brenne; Aud Øvervatn; Sabrina Habisov; Vladimir Kirkin; Trond Lamark; Terje Johansen
Journal:  EMBO Rep       Date:  2017-04-05       Impact factor: 8.807

Review 5.  Autophagy in malignant transformation and cancer progression.

Authors:  Lorenzo Galluzzi; Federico Pietrocola; José Manuel Bravo-San Pedro; Ravi K Amaravadi; Eric H Baehrecke; Francesco Cecconi; Patrice Codogno; Jayanta Debnath; David A Gewirtz; Vassiliki Karantza; Alec Kimmelman; Sharad Kumar; Beth Levine; Maria Chiara Maiuri; Seamus J Martin; Josef Penninger; Mauro Piacentini; David C Rubinsztein; Hans-Uwe Simon; Anne Simonsen; Andrew M Thorburn; Guillermo Velasco; Kevin M Ryan; Guido Kroemer
Journal:  EMBO J       Date:  2015-02-23       Impact factor: 11.598

Review 6.  Cellular adaptation to hypoxia through hypoxia inducible factors and beyond.

Authors:  Pearl Lee; Navdeep S Chandel; M Celeste Simon
Journal:  Nat Rev Mol Cell Biol       Date:  2020-03-06       Impact factor: 94.444

7.  BNIP3 promotes HIF-1α-driven melanoma growth by curbing intracellular iron homeostasis.

Authors:  Mónica Vara-Pérez; Matteo Rossi; Chris Van den Haute; Hannelore Maes; Maria Livia Sassano; Vivek Venkataramani; Bernhard Michalke; Erminia Romano; Kristine Rillaerts; Abhishek D Garg; Corentin Schepkens; Francesca M Bosisio; Jasper Wouters; Ana Isabel Oliveira; Peter Vangheluwe; Wim Annaert; Johannes V Swinnen; Jean Marie Colet; Joost J van den Oord; Sarah-Maria Fendt; Massimiliano Mazzone; Patrizia Agostinis
Journal:  EMBO J       Date:  2021-05-01       Impact factor: 11.598

Review 8.  Mitophagy in Cancer: A Tale of Adaptation.

Authors:  Monica Vara-Perez; Blanca Felipe-Abrio; Patrizia Agostinis
Journal:  Cells       Date:  2019-05-22       Impact factor: 6.600

Review 9.  Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.

Authors:  G L Semenza
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

10.  BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton.

Authors:  H Maes; S Van Eygen; D V Krysko; P Vandenabeele; K Nys; K Rillaerts; A D Garg; T Verfaillie; P Agostinis
Journal:  Cell Death Dis       Date:  2014-03-13       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.